Literature DB >> 519873

Metoclopramide induced growth hormone release in hypogonadal males.

H N Cohen, I D Hay, G H Beastall, J A Thomson.   

Abstract

The growth hormone (GH) response to 10 mg intravenous metoclopramide (MCP) ('Maxolon'--Beecham Laboratories) was determined in ten hypogonadal adult males. All the subjects responded with a peak growth hormone level greater than 14 mU/l within 1 hour of administration of MCP. Seven normal adult males did not respond to MCP administration. It is concluded that MCP stimulation may be a useful test for both prolactin and growth hormone reserve in hypogonadal males.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 519873     DOI： 10.1111/j.1365-2265.1979.tb03051.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN： 0300-0664            Impact factor:   3.478


  4 in total

Review 1.  Some current aspects of clinical and experimental neuroendocrinology with particular reference to growth hormone, thyrotropin and prolactin.

Authors:  M F Scanlon; M Pourmand; A M McGregor; M D Rodriguez-Arnao; K Hall; A Gomez-Pan; R Hall
Journal:  J Endocrinol Invest       Date:  1979 Jul-Sep       Impact factor: 4.256

2.  Clinical and pharmacological characterization of anomalous metoclopramide-induced growth hormone secretion in insulin-dependent diabetes mellitus.

Authors:  F Caviezel; G Lepore; M L Maglio; M Croci; G Comi; L Morricone
Journal:  Acta Diabetol Lat       Date:  1989 Apr-Jun

3.  Effect of metoclopramide on serum growth hormone levels in cirrhotic men.

Authors:  R Volpi; V Coiro; M Salvi; G Pelosi; P Mancini; P Chiodera
Journal:  J Endocrinol Invest       Date:  1983-04       Impact factor: 4.256

4.  Cholinergic and histaminergic involvement in the growth hormone releasing effect of an enkephalin analog FK 33-824 in man.

Authors:  A Peñalva; L Villanueva; F Casanueva; F Cavagnini; A Gomez-Pan; E E Müller
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.